ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $213,710 | -62.1% | 5,993 | -56.9% | 0.01% | -68.8% |
Q4 2022 | $563,378 | -30.7% | 13,890 | -43.5% | 0.02% | -33.3% |
Q3 2022 | $813,000 | -6.4% | 24,596 | -0.4% | 0.02% | -14.3% |
Q2 2022 | $869,000 | +53.3% | 24,687 | +100.3% | 0.03% | +55.6% |
Q1 2022 | $567,000 | -31.1% | 12,322 | -0.7% | 0.02% | -33.3% |
Q4 2021 | $823,000 | +6.2% | 12,411 | 0.0% | 0.03% | -12.9% |
Q3 2021 | $775,000 | -24.7% | 12,411 | -0.1% | 0.03% | -29.5% |
Q2 2021 | $1,029,000 | +24.9% | 12,426 | 0.0% | 0.04% | +18.9% |
Q1 2021 | $824,000 | -40.1% | 12,426 | -30.6% | 0.04% | -17.8% |
Q4 2020 | $1,375,000 | +5.4% | 17,915 | -40.9% | 0.04% | +7.1% |
Q3 2020 | $1,305,000 | -51.2% | 30,317 | -51.0% | 0.04% | -47.5% |
Q2 2020 | $2,673,000 | -13.6% | 61,897 | -42.4% | 0.08% | -7.0% |
Q1 2020 | $3,093,000 | -64.8% | 107,524 | -22.4% | 0.09% | -46.6% |
Q4 2019 | $8,786,000 | +16.2% | 138,511 | -48.4% | 0.16% | +20.1% |
Q3 2019 | $7,562,000 | +210.0% | 268,348 | +191.6% | 0.13% | +243.6% |
Q2 2019 | $2,439,000 | +256.1% | 92,031 | +146.7% | 0.04% | +290.0% |
Q1 2019 | $685,000 | – | 37,303 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |